Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Denmark
/
Healthcare
Create a narrative
Healthcare Danish Community
Our community narratives are driven by numbers and valuation.
Create a narrative
All companies
Popular
Undervalued
Overvalued
Healthcare Danish Investing Ideas
NNIT
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Integration And New Systems In 2024 Will Streamline Operations And Lower Costs
Key Takeaways Strategic initiatives, such as ERP integration and restructuring, are set to enhance operational efficiency, profitability, and market competitiveness. Expansion in key sectors and strong customer satisfaction indicate steady growth, with organic growth targets outpacing the market.
View narrative
DKK 85.00
FV
18.4% undervalued
intrinsic discount
7.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
EMBL
Embla Medical hf
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
New Product Launches And Manufacturing Improvements Will Shape Future Reach
Key Takeaways New product launches, Medicare expansion, and international growth initiatives are expected to drive sales and boost revenue. Cost reduction efforts, manufacturing efficiency, and share buyback program could enhance profitability and EPS growth.
View narrative
DKK 33.15
FV
2.3% undervalued
intrinsic discount
8.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
Ambu
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
New SureSight Launch Will Strengthen Leadership In Airway Visualization
Key Takeaways Strong growth in Endoscopy Solutions and new product launches suggest future revenue boosts in key medical sectors and airway visualization. Operational improvements and strategic focus on innovation indicate enhanced net margins and sustained earnings growth prospects.
View narrative
DKK 147.11
FV
32.8% undervalued
intrinsic discount
12.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
Demant
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Expanding Into Denmark, Germany, And Italy Will Strengthen Future Position In Hearing Care Market
Key Takeaways Strategic divestments and focus on hearing healthcare aim to reduce complexity, improve margins, and streamline operations. Expansion of high-performing product portfolio and bolt-on acquisitions target growth, leveraging efficient innovation and enhanced market presence.
View narrative
DKK 296.12
FV
8.1% undervalued
intrinsic discount
7.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
Coloplast
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Introducing Luja And SenSura Mio To New Markets Will Strengthen Future Market Share
Key Takeaways Growth in Continence and Ostomy Care, driven by new products, could boost revenue and market share, aided by positive market feedback. Simplification and expansion strategies, including divestment and manufacturing improvements, may enhance margins and drive profitability.
View narrative
DKK 909.87
FV
33.4% undervalued
intrinsic discount
8.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
4 days ago
author updated this narrative
Ambu
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Aging Population Will Boost Global Single-use Endoscopy Adoption
Key Takeaways Rapid hospital conversion to single-use solutions, infection control trends, and minimal churn could accelerate revenue and margin growth beyond current expectations. Early adoption of sustainable, reusable endoscopy, strong cash reserves, and digital innovation position Ambu for premium pricing, market share gains, and strategic acquisitions.
View narrative
DKK 147.00
FV
32.8% undervalued
intrinsic discount
12.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Ambu
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Global Competition And Regulatory Hurdles Will Depress Endoscopy Demand
Key Takeaways Sustainability concerns and regulatory pressure threaten demand for single-use devices, undermining Ambu's growth and market position in key regions. Rising costs, tougher competition, and harsher regulations are squeezing margins and hindering both expansion and earnings potential.
View narrative
DKK 94.54
FV
4.5% overvalued
intrinsic discount
10.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
Value any company in seconds
Popular companies